Sabra Health Care REIT Inc (SBRA) Expected to Post Quarterly Sales of $144.87 Million

Equities analysts expect Sabra Health Care REIT Inc (NASDAQ:SBRA) to announce $144.87 million in sales for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Sabra Health Care REIT’s earnings, with estimates ranging from $143.39 million to $145.70 million. Sabra Health Care REIT posted sales of $166.09 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 12.8%. The business is scheduled to issue its next earnings results on Wednesday, May 8th.

On average, analysts expect that Sabra Health Care REIT will report full year sales of $576.67 million for the current financial year, with estimates ranging from $554.48 million to $594.28 million. For the next fiscal year, analysts forecast that the firm will post sales of $576.25 million, with estimates ranging from $542.87 million to $624.20 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that cover Sabra Health Care REIT.

A number of equities research analysts have issued reports on SBRA shares. BidaskClub raised shares of Sabra Health Care REIT from a “sell” rating to a “hold” rating in a report on Tuesday, January 29th. Zacks Investment Research raised shares of Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a report on Thursday, February 21st. ValuEngine lowered shares of Sabra Health Care REIT from a “hold” rating to a “sell” rating in a report on Tuesday, March 5th. SunTrust Banks lowered shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a report on Tuesday, December 18th. Finally, BMO Capital Markets reissued a “hold” rating and issued a $17.00 price target on shares of Sabra Health Care REIT in a report on Monday, January 14th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. Sabra Health Care REIT has a consensus rating of “Hold” and an average target price of $21.33.

Sabra Health Care REIT stock traded down $0.16 during trading hours on Friday, reaching $19.47. The stock had a trading volume of 4,229,778 shares, compared to its average volume of 2,294,432. The firm has a market cap of $3.50 billion, a PE ratio of 8.50, a price-to-earnings-growth ratio of 2.53 and a beta of 1.00. Sabra Health Care REIT has a 52 week low of $15.70 and a 52 week high of $23.83. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.99.

The company also recently declared a quarterly dividend, which was paid on Thursday, February 28th. Shareholders of record on Friday, February 15th were issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 9.24%. The ex-dividend date was Thursday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 78.60%.

Several institutional investors and hedge funds have recently made changes to their positions in SBRA. US Bancorp DE boosted its stake in shares of Sabra Health Care REIT by 199.5% during the 3rd quarter. US Bancorp DE now owns 17,070 shares of the real estate investment trust’s stock valued at $394,000 after purchasing an additional 11,371 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Sabra Health Care REIT by 10.0% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 41,438 shares of the real estate investment trust’s stock valued at $958,000 after purchasing an additional 3,771 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Sabra Health Care REIT by 51.6% during the 3rd quarter. SG Americas Securities LLC now owns 95,215 shares of the real estate investment trust’s stock valued at $2,201,000 after purchasing an additional 32,421 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Sabra Health Care REIT by 221.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,779,693 shares of the real estate investment trust’s stock valued at $41,147,000 after purchasing an additional 1,226,574 shares in the last quarter. Finally, MML Investors Services LLC bought a new stake in shares of Sabra Health Care REIT during the 3rd quarter valued at about $222,000. 86.87% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Health Care REIT

As of December 31, 2018, Sabra's investment portfolio included 470 real estate properties held for investment (consisting of (i) 335 Skilled Nursing/Transitional Care facilities, (ii) 90 Senior Housing communities (“Senior Housing – Leased”), (iii) 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing – Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan and (iv) 18 other loans), nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Featured Story: Guidelines for Successful Channel Trading

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.